Kathy Remington, PhD BioReliance
Kathy Remington, PhD BioReliance
Kathryn Martin Remington is a member of BioReliance’s Field Development Services group and provides U.S. clients with technical and regulatory support.
Kathy came to BioReliance in 2010 from Catalent Pharma Solutions where she established their viral clearance program and managed it for 7 years. Prior to that, Kathy was the Section Head of the Viral Validation group for Bayer Healthcare. During her nearly 20 years in viral clearance, she has authored a number of publications on the viral safety of biopharmaceuticals. Kathy earned her M.S. and Ph.D. degrees in Microbiology from the University of Montana.